Yuhong Du Selected Research

Phosphoserine

9/2011	Discovery and structural characterization of a small molecule 14-3-3 protein-protein interaction inhibitor.
9/2011	14-3-3 proteins as potential therapeutic targets.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yuhong Du Research Topics

Disease

32	Neoplasms (Cancer) 09/2022 - 04/2006
4	Breast Neoplasms (Breast Cancer) 01/2021 - 02/2009
4	Lung Neoplasms (Lung Cancer) 01/2017 - 11/2010
4	Neurodegenerative Diseases (Neurodegenerative Disease) 09/2011 - 04/2006
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2015 - 02/2013
3	Inflammation (Inflammations) 06/2013 - 10/2007
2	Open-Angle Glaucoma (Glaucoma, Open Angle) 01/2018 - 02/2014
2	Glaucoma 01/2018 - 02/2014
2	Neoplasm Metastasis (Metastasis) 01/2018 - 01/2017
2	Pathologic Processes 01/2016 - 09/2011
2	Infections 04/2015 - 10/2007
2	Adenocarcinoma of Lung 01/2009 - 01/2008
1	Ovarian Neoplasms (Ovarian Cancer) 09/2022
1	Microsatellite Instability 01/2021
1	Carcinogenesis 01/2021
1	Stomach Neoplasms (Stomach Cancer) 01/2021
1	Heart Failure 11/2020
1	Cardiotoxicity 11/2020
1	Glioblastoma (Glioblastoma Multiforme) 10/2020
1	Body Weight (Weight, Body) 01/2020
1	Carcinoma (Carcinomatosis) 01/2020
1	Metabolic Diseases (Metabolic Disease) 01/2020
1	Obesity 01/2020
1	Triple Negative Breast Neoplasms 01/2020
1	Prostatic Neoplasms (Prostate Cancer) 01/2018
1	Alzheimer Disease (Alzheimer's Disease) 01/2017
1	Lymphoma (Lymphomas) 05/2015
1	DiGeorge Syndrome (Syndrome, DiGeorge) 02/2015
1	Proteostasis Deficiencies 02/2014
1	Multiple Myeloma 08/2013
1	Lung Diseases (Lung Disease) 02/2013
1	Status Epilepticus (Complex Partial Status Epilepticus) 02/2012
1	Coronavirus Infections 07/2011

Drug/Important Bio-Agent (IBA)

15	Proteins (Proteins, Gene)FDA Link 01/2022 - 04/2006
6	Biological ProductsIBA 01/2021 - 11/2010
4	Pharmaceutical PreparationsIBA 09/2022 - 01/2017
4	CurcuminIBA 08/2013 - 09/2008
3	Heat-Shock Proteins (Heat-Shock Protein)IBA 01/2015 - 10/2007
2	ErbB Receptors (EGF Receptor)IBA 10/2020 - 01/2009
2	Messenger RNA (mRNA)IBA 01/2020 - 02/2012
2	Protein Isoforms (Isoforms)IBA 02/2018 - 01/2008
2	olfactomedinIBA 01/2018 - 02/2014
2	trabecular meshwork-induced glucocorticoid response proteinIBA 01/2018 - 02/2014
2	asparaginylendopeptidase (legumain)IBA 01/2017 - 01/2017
2	Transcription Factors (Transcription Factor)IBA 01/2017 - 03/2009
2	14-3-3 Proteins (14-3-3 Protein)IBA 05/2014 - 11/2008
2	PhosphoserineIBA 09/2011 - 09/2011
2	Eukaryotic Initiation Factor-4F (EIF4F)IBA 07/2011 - 01/2011
1	taxaneIBA 09/2022
1	Biomarkers (Surrogate Marker)IBA 09/2022
1	Taxoids (Taxanes)IBA 09/2022
1	SGI-1027IBA 01/2021
1	Ro 31-8220IBA 01/2021
1	SurvivinIBA 01/2021
1	Adhesives (Glues)IBA 01/2021
1	Melphalan (Alkeran)FDA LinkGeneric 11/2020
1	Transforming Growth Factors (Transforming Growth Factor)IBA 11/2020
1	Antineoplastic Agents (Antineoplastics)IBA 11/2020
1	3-nitrophenyl 3-piperidinecarboxylate (MNPC)IBA 10/2020
1	Small Interfering RNA (siRNA)IBA 10/2020
1	MAP Kinase Kinase 3IBA 01/2020
1	Immunologic Factors (Immunomodulators)IBA 01/2019
1	MethyltransferasesIBA 02/2018
1	Dopamine D2 Receptors (Dopamine D2 Receptor)IBA 01/2018
1	Bromocriptine (Parlodel)FDA LinkGeneric 01/2018
1	Docetaxel (Taxotere)FDA Link 01/2018
1	glucose-regulated proteinsIBA 01/2018
1	XanthineIBA 01/2017
1	Amyloid (Amyloid Fibrils)IBA 01/2017
1	palbociclibIBA 01/2017
1	Cysteine Proteases (Cysteine Protease)IBA 01/2017
1	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 01/2017
1	Matrix Metalloproteinases (MMPs)IBA 01/2017
1	Doxorubicin (Adriamycin)FDA LinkGeneric 05/2015
1	Glycoproteins (Glycoprotein)IBA 04/2015
1	CalpainIBA 02/2015
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 01/2015
1	Focal Adhesion Protein-Tyrosine KinasesIBA 01/2015
1	LigandsIBA 02/2014
1	Thalidomide (Thalomid)FDA Link 08/2013
1	TubulinIBA 08/2013
1	crotalid hemorrhagic factor B (NHFb)IBA 08/2013
1	Phosphotransferases (Kinase)IBA 06/2013
1	MAP Kinase Kinase Kinase 5IBA 06/2013
1	ophiopogonin BIBA 02/2013
1	Prostaglandins EIBA 02/2012
1	Pilocarpine (Ocusert)FDA LinkGeneric 02/2012
1	Dinoprostone (PGE2)FDA Link 02/2012
1	Threonine (L-Threonine)FDA Link 09/2011
1	Phosphothreonine (Threonine Phosphate)IBA 09/2011
1	Carrier Proteins (Binding Protein)IBA 09/2011
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 11/2010
1	SB 203580IBA 11/2010

Therapy/Procedure

6	Therapeutics 01/2020 - 02/2009
3	Drug Therapy (Chemotherapy) 01/2018 - 09/2008
1	Precision Medicine 01/2022
1	Transplantation 01/2020
1	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2020
1	Oral Administration 01/2017
1	Chinese Traditional Medicine (Traditional Chinese Medicine) 02/2013